STAT3 and neoplasm: Conversely, inhibition of STAT3 or STAT5 signaling or genetic deletion of the fatty acid translocase CD36 inhibits the activation of oxidative metabolism and prevents the immunosuppressive function of MDSC leading to enhanced CD8+ T cell functionality and delay in tumor growth.